BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 28267448)

  • 1. Imaging of Prostate Cancer Using
    Castellucci P; Ceci F; Fanti S
    PET Clin; 2017 Apr; 12(2):137-143. PubMed ID: 28267448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging of Prostate Cancer Using
    Castellucci P; Ceci F; Fanti S
    Urol Clin North Am; 2018 Aug; 45(3):481-487. PubMed ID: 30031467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure?
    Goldstein J; Even-Sapir E; Ben-Haim S; Saad A; Spieler B; Davidson T; Berger R; Weiss I; Appel S; Lawrence YR; Symon Z
    Am J Clin Oncol; 2017 Jun; 40(3):256-259. PubMed ID: 25319322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging of Prostate Cancer Using
    Hodolič M
    PET Clin; 2017 Apr; 12(2):173-184. PubMed ID: 28267451
    [No Abstract]   [Full Text] [Related]  

  • 5. New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.
    Evangelista L; Briganti A; Fanti S; Joniau S; Reske S; Schiavina R; Stief C; Thalmann GN; Picchio M
    Eur Urol; 2016 Jul; 70(1):161-175. PubMed ID: 26850970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (11)C-choline PET/CT and multiparametric MRI in patients with biochemical relapse of prostate cancer.
    Garcia JR; Romera N; Cozar M; Soler M; Moragas M; Escobar M
    Actas Urol Esp; 2015 May; 39(4):259-63. PubMed ID: 25454265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is 11C-choline Positron Emission Tomography/Computed Tomography Accurate to Detect Nodal Relapses of Prostate Cancer After Biochemical Recurrence? A Multicentric Study Based on Pathologic Confirmation from Salvage Lymphadenectomy.
    Oderda M; Joniau S; Palazzetti A; Falcone M; Melloni G; Van Den Bossche H; Deconinck S; Zattoni F; Karnes RJ; Gontero P
    Eur Urol Focus; 2018 Mar; 4(2):288-293. PubMed ID: 30205893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Prostate Cancer with 11C-Choline PET/CT for Treatment Planning, Response Assessment, and Prognosis.
    Ceci F; Castellucci P; Mapelli P; Incerti E; Picchio M; Fanti S
    J Nucl Med; 2016 Oct; 57(Suppl 3):49S-54S. PubMed ID: 27694172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET/CT and MRI directed extended salvage radiotherapy in recurrent prostate cancer with lymph node metastases.
    Rischke HC; Eiberger AK; Volegova-Neher N; Henne K; Krauss T; Grosu AL; Jilg CA
    Adv Med Sci; 2016 Sep; 61(2):212-218. PubMed ID: 26895459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (11)C-Choline PET/CT for restaging prostate cancer. Results from 4,426 scans in a single-centre patient series.
    Graziani T; Ceci F; Castellucci P; Polverari G; Lima GM; Lodi F; Morganti AG; Ardizzoni A; Schiavina R; Fanti S
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1971-9. PubMed ID: 27277279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early biochemical relapse after radical prostatectomy: which prostate cancer patients may benefit from a restaging 11C-Choline PET/CT scan before salvage radiation therapy?
    Castellucci P; Ceci F; Graziani T; Schiavina R; Brunocilla E; Mazzarotto R; Pettinato C; Celli M; Lodi F; Fanti S
    J Nucl Med; 2014 Sep; 55(9):1424-9. PubMed ID: 24935990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histological verification of 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer.
    Schilling D; Schlemmer HP; Wagner PH; Böttcher P; Merseburger AS; Aschoff P; Bares R; Pfannenberg C; Ganswindt U; Corvin S; Stenzl A
    BJU Int; 2008 Aug; 102(4):446-51. PubMed ID: 18410442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [11C]choline positron emission tomography/computerized tomography for early detection of prostate cancer recurrence in patients with low increasing prostate specific antigen.
    Giovacchini G; Picchio M; Garcia-Parra R; Mapelli P; Briganti A; Montorsi F; Gianolli L; Messa C
    J Urol; 2013 Jan; 189(1):105-10. PubMed ID: 23164385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective evaluation of [
    Schwarzenböck SM; Eiber M; Kundt G; Retz M; Sakretz M; Kurth J; Treiber U; Nawroth R; Rummeny EJ; Gschwend JE; Schwaiger M; Thalgott M; Krause BJ
    Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2105-2113. PubMed ID: 27317482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of positron emission tomography/computed tomography imaging with radiolabeled choline analogues in prostate cancer.
    Navarro-Pelayo Láinez MM; Rodríguez-Fernández A; Gómez-Río M; Vázquez-Alonso F; Cózar-Olmo JM; Llamas-Elvira JM
    Actas Urol Esp; 2014 Nov; 38(9):613-21. PubMed ID: 24548475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [PET/CT with (11)C-choline and (18)F-FDG in patients with elevated PSA after radical treatment of a prostate cancer].
    García JR; Soler M; Blanch MA; Ramírez I; Riera E; Lozano P; Pérez X; Delgado E; Carrio I; Lomeña F
    Rev Esp Med Nucl; 2009; 28(3):95-100. PubMed ID: 19558948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbon 11-choline positron emission tomography/computed tomography and palliative local therapy for castration-resistant prostate cancer.
    Nozaki K; Kawai T; Fujimura T; Matsui H; Teshima T; Oshina T; Takahashi A; Sato Y; Yamada D; Azuma T; Hotta M; Nakajima K; Nakayama H; Minamimoto R; Kume H
    Int Urol Nephrol; 2019 Oct; 51(10):1763-1769. PubMed ID: 31325132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic performance of bone scintigraphy and (11)C-Choline PET/CT in the detection of bone metastases in patients with biochemical recurrence of prostate cancer].
    Garcia JR; Moreno C; Valls E; Cozar P; Bassa P; Soler M; Alvarez-Moro FJ; Moragas M; Riera E
    Rev Esp Med Nucl Imagen Mol; 2015; 34(3):155-61. PubMed ID: 25443648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of (11)C-choline PET/CT on the treatment planning for salvage radiation therapy in patients with biochemical recurrence of prostate cancer.
    Souvatzoglou M; Krause BJ; Pürschel A; Thamm R; Schuster T; Buck AK; Zimmermann F; Molls M; Schwaiger M; Geinitz H
    Radiother Oncol; 2011 May; 99(2):193-200. PubMed ID: 21620494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of
    Gómez-de la Fuente FJ; Martínez-Rodríguez I; de Arcocha-Torres M; Quirce R; Jiménez-Bonilla J; Martínez-Amador N; Banzo I
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(3):156-162. PubMed ID: 29137875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.